Filing Details

Accession Number:
0001683168-23-002424
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-17 08:17:37
Reporting Period:
2023-04-10
Accepted Time:
2023-04-17 08:17:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1729427 Cns Pharmaceuticals Inc. CNSP Pharmaceutical Preparations (2834) 822318545
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1793252 Jerzy Gumulka C/O Cns Pharmaceuticals, Inc.
100 West Loop South, Suite 900
Houston TX 77027
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-10 7,173 $0.74 7,173 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct